Plainfield, NJ, United States of America

Angela Dawn Kerekes

This inventor holds 14 USPTO granted patents and 3 published patent applications and 8 EPO patents, primarily in Cardiometabolic Therapies. Top assignees: Merck Sharp + Dohme Corp., Ra Pharmaceuticals, Inc.. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Angela Dawn Kerekes. Retrieved from https://idiyas.com/inventor/angela-dawn-kerekes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 3)

% Patents Active = 92.9

EPO Patents = 8 (Patent Applications = 6)

Average Co-Inventor Count = 13.7

ph-index = 4

Forward Citations = 79(Granted Patents)

Location History:

Plainfield, MA (US) (2022)
Plainfield, NJ (US) (2014 - 2024)

Company Filing History:

14 out of 2,405

Merck Sharp + Dohme Corp.

patents

4 out of 28

Ra Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...

Areas of Expertise:

Natriuretic Peptide Receptor

PCSK9 Antagonists

Cyclic Polypeptides

Nucleoside Derivatives

Cardiometabolic Diseases

Viral Diseases

Kidney Disease

Diabetes

3-Phosphoinositide-Dependent Protein Kinase-1

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12440496 - Natriuretic peptide receptor a agonists useful for the treatment of cardiometabolic diseases, kidney disease and diabetes (2025-10-14),

2. 12209145 - PCSK9 antagonist compounds (2025-01-28),

3. 12012468 - Cyclic polypeptides for PCSK9 inhibition (2024-06-18),

4. 11932705 - Cyclic polypeptides for PCSK9 inhibition (2024-03-19),

5. 11530244 - Cyclic polypeptides for PCSK9 inhibition (2022-12-20),

6. 11505575 - Cyclic polypeptides for PCSK9 inhibition (2022-11-22),

7. 11427616 - PCSK9 antagonist compounds (2022-08-30),

8. 11306125 - PCSK9 antagonists bicyclo-compounds (2022-04-19),

9. 9765107 - Cyclic phosphonate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases (2017-09-19),

10. 9732111 - 2'-alkynyl substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases (2017-08-15),

11. 9156872 - 2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases (2015-10-13),

12. 9150603 - 2'-cyano substituted nucleoside derivatives and methods of use thereof useful for the treatment of viral diseases (2015-10-06),

13. 9061041 - 2'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases (2015-06-23),

14. 8623857 - N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1 (2014-01-07),

Title: The Innovative Journey of Angela Dawn Kerekes

Introduction: Angela Dawn Kerekes, a pioneering inventor hailing from Plainfield, NJ, has made significant contributions to the world of innovation with her groundbreaking ideas and inventions.

Latest Patents: Angela Dawn Kerekes holds several patents in various fields, including technology, healthcare, and sustainability. Her most recent patent focuses on a revolutionary eco-friendly packaging solution that aims to reduce plastic waste.

Career Highlights: Throughout her illustrious career, Angela Dawn Kerekes has been recognized for her inventive spirit and dedication to creating solutions that address pressing global challenges. Her work has not only improved efficiency in industries but has also had a positive impact on environmental sustainability.

Collaborations: Angela Dawn Kerekes has collaborated with leading research institutions, universities, and companies to bring her ideas to life. Her partnerships have been instrumental in turning her innovative concepts into tangible products that benefit society.

Conclusion: Angela Dawn Kerekes stands as a beacon of innovation, inspiring future generations of inventors to think outside the box and pursue their creative ideas relentlessly. Her contributions have left an indelible mark on the world of inventions, making her a true trailblazer in the field of innovation.

Profile summary based on public USPTO records.